Login / Signup

Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China.

Wei FangYan LiRong MoJianjian WangLi QiuChuangyi OuZhongqiang LinZhidong HuangHuiyu FengXuetao HeWeizhi WangPeipei XuLihua WangHao RanWeibin Liu
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
The southern MG population had a significantly higher prevalence and a lower response threshold to medication than the northern MG population. These results are calling for further investigations on the genetic, cultural, and environmental variations of the Chinese MG populations between north and south.
Keyphrases
  • healthcare
  • myasthenia gravis
  • adverse drug
  • risk factors
  • genome wide
  • health insurance
  • tertiary care
  • affordable care act
  • risk assessment
  • human health
  • health information
  • long term care